U.S. Top High Growth Tech & AI Stocks - Spotless Financials

Palantir Technologies

Market Cap: US$403.9b

Palantir Technologies Inc. builds and deploys software platforms for the intelligence community to assist in counterterrorism investigations and operations in the United States, the United Kingdom, and internationally.

RenovoRx

Market Cap: US$46.5m

A clinical-stage biopharmaceutical company, engages in the developing of targeted combination therapies to enhance therapeutic outcomes for cancer patients undergoing treatment.

Vanda Pharmaceuticals

Market Cap: US$258.8m

A biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs worldwide.

Zscaler

Market Cap: US$45.2b

Operates as a cloud security company worldwide.

ADMA Biologics

Market Cap: US$3.7b

A biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.

OS Therapies

Market Cap: US$69.6m

A clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States.

Aldeyra Therapeutics

Market Cap: US$297.8m

A biotechnology company, discovers and develops therapies designed to treat immune-mediated and metabolic diseases.

Gorilla Technology Group

Market Cap: US$508.6m

Provides solutions in security, network, business intelligence, and Internet of Things (IoT) technology in Taiwan and the United Kingdom.

Circle Internet Group

Market Cap: US$31.2b

Operates as a platform, network, and market infrastructure for stablecoin and blockchain applications.

Workday

Market Cap: US$58.5b

Provides enterprise cloud applications in the United States and internationally.

ACADIA Pharmaceuticals

Market Cap: US$4.0b

A biopharmaceutical company, focuses on the development and commercialization of medicines for central nervous system (CNS) disorders and rare diseases in the United States.

Atlassian

Market Cap: US$45.6b

Provides a collaboration software that enables organizations to connect all teams through a system of work that unlocks productivity at scale worldwide.

Cellebrite DI

Market Cap: US$4.2b

Develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific.

HubSpot

Market Cap: US$26.5b

Provides a cloud-based customer relationship management (CRM) platform for businesses in the Americas, Europe, and the Asia Pacific.

Zeta Global Holdings

Market Cap: US$4.8b

Operates an omnichannel data-driven cloud platform that provides enterprises with consumer intelligence and marketing automation software in the United States and internationally.

Reddit

Market Cap: US$49.9b

Operates a digital community in the United States and internationally.

Krystal Biotech

Market Cap: US$4.5b

A commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States.

Anavex Life Sciences

Market Cap: US$769.6m

Operates as a biopharmaceutical company.

Commvault Systems

Market Cap: US$8.4b

Provides a cyber resilience platform for protecting and recovering data and cloud-native applications in the Americas and internationally.

Creative Medical Technology Holdings

Market Cap: US$9.0m

A commercial-stage biotechnology company, focuses on novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics in the United States.

Trade Desk

Market Cap: US$22.3b

Operates as a technology company in the United States and internationally.

Protalix BioTherapeutics

Market Cap: US$155.5m

A biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on the ProCellEx plant cell-based protein expression system.

Glimpse Group

Market Cap: US$31.6m

An immersive technology company provides enterprise focused virtual reality (VR), augmented reality (AR), and spatial computing software and services in the United States.

Evaxion

Market Cap: US$18.6m

A clinical-stage biotech company, develops artificial intelligence-powered immunology vaccines.

MNTN

Market Cap: US$1.5b

Operates a technology platform that brings performance marketing to Connected TV.

Protagonist Therapeutics

Market Cap: US$3.6b

A biopharmaceutical company, develops peptide therapeutics for hematology and blood disorders, and inflammatory and immunomodulatory diseases.

Aprea Therapeutics

Market Cap: US$8.8m

A clinical-stage biopharmaceutical company, focuses on developing and commercializing novel synthetic lethality-based cancer therapeutics that targets DNA damage response pathways.

Arcturus Therapeutics Holdings

Market Cap: US$492.3m

Engages in the development of infectious disease vaccines and other products within liver and respiratory rare diseases.

Applied Optoelectronics

Market Cap: US$1.8b

Designs, manufactures, and sells fiber-optic networking products in the United States, Taiwan, and China.

Pure Storage

Market Cap: US$28.5b

Provides data storage and management technologies, products, and services in the United States and internationally.

KVH Industries

Market Cap: US$120.2m

Engages in the design, development, manufacture, and marketing of mobile connectivity solutions for the marine and land mobile markets in the United States and internationally.

Exelixis

Market Cap: US$10.5b

An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.

Roku

Market Cap: US$13.8b

Operates a TV streaming platform in the United States and internationally.

VTEX

Market Cap: US$764.2m

Provides software-as-a-service digital commerce platform for enterprise brands and retailers.

CarGurus

Market Cap: US$3.6b

Operates an online automotive platform for buying and selling vehicles in the United States and internationally.

Kiniksa Pharmaceuticals International

Market Cap: US$2.7b

A biopharmaceutical company, developing and commercializing novel therapies for diseases with unmet need and focuses on cardiovascular indications worldwide.